Downtrend on the daily chart: below its 200-day average, above its 50-day · 50-day below the 200-day · SuperTrend down since Jul 23 · inside the Ichimoku cloud · RSI 39 · MACD above its signal · at its 52-week low
None of the 29 investors followed here reported a position in NSHS-X.CN in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 20.0 | 0.0 | -33.3 | 25.0 | -20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −20.0% | ||
| 2025 | 100.0 | 0.0 | -22.2 | -21.4 | -36.4 | 0.0 | -28.6 | 20.0 | 0.0 | 0.0 | -16.7 | 0.0 | −44.4% |
| 2024 | 0.0 | 0.0 | 150.0 | -40.0 | 100.0 | 66.7 | -10.0 | -22.2 | 14.3 | -25.0 | 16.7 | 28.6 | +350.0% |
| 2023 | 40.0 | 42.9 | 0.0 | -30.0 | -28.6 | 0.0 | 20.0 | -33.3 | -50.0 | 50.0 | -66.7 | 100.0 | −60.0% |
| 2022 | -29.6 | -21.1 | -20.0 | -16.7 | -30.0 | 0.0 | -21.4 | -9.1 | 30.0 | -46.2 | 0.0 | -28.6 | −90.7% |
| 2021 | 100.0 | 16.7 | -14.3 | -16.7 | 20.0 | -16.7 | -38.0 | 0.0 | 9.7 | -35.3 | 6.8 | 14.9 | −10.0% |
| 2020 | -16.7 | -40.0 | 33.3 | -50.0 | 25.0 | -20.0 | 0.0 | 25.0 | -20.0 | 0.0 | 0.0 | -25.0 | −75.0% |
| 2019 | 47.8 | 22.1 | -10.8 | -14.9 | -20.6 | -20.0 | -17.5 | -42.4 | 21.1 | -65.2 | 50.0 | 0.0 | −73.9% |
| 2018 | 32.4 | -42.2 | 3.8 | -11.1 | -12.5 | -20.2 | 25.4 | 15.5 | -17.5 | -13.7 | -13.0 | -23.3 | −66.2% |
| 2017 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 23.6 | +23.6% |
| 2016 | -26.0 | 13.5 | 4.8 | -9.1 | 35.0 | -14.8 | 19.6 | 9.1 | 16.7 | 0.0 | -14.3 | 83.3 | +120.0% |
| 2015 | 104.2 | -6.1 | 10.9 | 29.4 | -12.1 | -5.2 | -27.3 | -5.0 | -5.3 | 36.1 | -26.5 | 38.9 | +108.3% |
| 2014 | 0.0 | 100.0 | -66.7 | -10.0 | -22.2 | -20.0 | -17.9 | -21.7 | 27.8 | 47.8 | -17.6 | -14.3 | −68.0% |
| 2013 | -40.0 | -33.3 | 0.0 | 0.0 | 0.0 | -75.0 | 0.0 | 100.0 | -50.0 | 0.0 | 0.0 | 0.0 | −90.0% |
| 2012 | 26.1 | -8.6 | -17.0 | -59.1 | -22.2 | -7.1 | -7.7 | 0.0 | 8.3 | 15.4 | -26.7 | -9.1 | −78.3% |
| 2011 | 9.0 | -14.1 | 20.5 | -20.5 | -28.6 | -12.0 | -18.2 | -16.7 | -30.0 | -4.8 | 40.0 | -17.9 | −70.5% |
| 2010 | 45.8 | 14.3 | 0.0 | -35.0 | 0.0 | 46.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 310.5 | +550.0% |
| 2009 | -25.0 | 66.7 | -53.3 | 0.0 | 128.6 | 0.0 | 0.0 | 0.0 | 0.0 | 125.0 | -44.4 | 20.0 | +100.0% |
| 2008 | -16.0 | 19.0 | -32.0 | -17.6 | 171.4 | -26.3 | 7.1 | -20.0 | -50.0 | -16.7 | -60.0 | -57.1 | −93.1% |
| 2007 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -31.8 | -4.4 | -39.5 | -5.8 | -10.2 | -27.3 | -21.9 | −81.1% |
No insider transactions reported for NSHS-X.CN.
No member of Congress has disclosed a NSHS-X.CN trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No analyst coverage for this instrument.
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, animal health, and other industries. NanoSphere Health Sciences Inc. is headquartered in Vancouver, Canada.
No recent headlines.